Dominari Holdings Inc. (DOMH)
NASDAQ: DOMH · Real-Time Price · USD
4.070
+0.080 (2.01%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Dominari Holdings Market Cap
Dominari Holdings has a market cap or net worth of $59.60 million as of April 21, 2025. Its market cap has increased by 316.79% in one year.
Market Cap
59.60M
Enterprise Value
55.78M
1-Year Change
316.79%
Ranking
Category
Stock Price
$4.07
Market Cap Chart
Since December 1, 1998, Dominari Holdings's market cap has increased from $50.00M to $59.60M, an increase of 19.20%. That is a compound annual growth rate of 0.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2025 | 25.00M | 303.23% |
Dec 31, 2024 | 6.20M | -55.07% |
Dec 29, 2023 | 13.80M | -23.33% |
Dec 30, 2022 | 18.00M | -65.78% |
Dec 31, 2021 | 52.60M | 72.46% |
Dec 31, 2020 | 30.50M | 702.63% |
Dec 31, 2019 | 3.80M | -30.91% |
Dec 31, 2018 | 5.50M | -36.78% |
Dec 29, 2017 | 8.70M | 74.00% |
Dec 30, 2016 | 5.00M | - |
Dec 31, 2015 | 5.00M | -83.82% |
Dec 31, 2014 | 30.90M | 57.65% |
Dec 31, 2013 | 19.60M | 317.02% |
Dec 31, 2012 | 4.70M | 30.56% |
Dec 30, 2011 | 3.60M | -76.32% |
Dec 31, 2010 | 15.20M | -6.75% |
Dec 31, 2009 | 16.30M | 146.97% |
Dec 31, 2008 | 6.60M | -58.23% |
Dec 31, 2007 | 15.80M | -49.36% |
Dec 29, 2006 | 31.20M | -25.18% |
Dec 30, 2005 | 41.70M | 6.11% |
Dec 31, 2004 | 39.30M | -45.34% |
Dec 31, 2003 | 71.90M | -18.57% |
Dec 31, 2002 | 88.30M | -11.26% |
Dec 31, 2001 | 99.50M | 85.98% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 734.57B |
UnitedHealth Group | 389.05B |
Johnson & Johnson | 378.15B |
AbbVie | 301.01B |
Novo Nordisk | 284.50B |
Abbott Laboratories | 225.27B |
Novartis AG | 209.93B |
AstraZeneca | 208.11B |